<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02526667</url>
  </required_header>
  <id_info>
    <org_study_id>R15-029</org_study_id>
    <nct_id>NCT02526667</nct_id>
  </id_info>
  <brief_title>Preoperative Chlorhexidine Gluconate (CHG) Cloth on Healthy Volunteers</brief_title>
  <official_title>Assessment of the Antimicrobial Efficacy of 2% CHG Cloth Preoperative Skin Preparation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medline Industries</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medline Industries</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluate the effects of Chlorhexidine Gluconate (CHG) cloth on the reduction of bacteria on&#xD;
      the skin.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Examine the antimicrobial cloth effects on normal flora bacteria of the abdomen and groin&#xD;
      areas post Chlorhexidine Gluconate (CHG) application.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2015</start_date>
  <completion_date type="Actual">December 2015</completion_date>
  <primary_completion_date type="Actual">December 2015</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Responder Rates (%) of Sites Identified for Bacterial Reduction on the Abdomen and Groin</measure>
    <time_frame>10 minutes, 6 hours, 8 hours</time_frame>
    <description>Log10 reduction in bacteria on the skin evaluated at 10 minutes, 6 hours and 8 hours after treatment. Responder rates (%) are the percentage of sites identified that produced a 2-Log and 3-Log reduction from baseline for abdomen and groin sites respectively.</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">340</enrollment>
  <condition>Surgery</condition>
  <arm_group>
    <arm_group_label>Chlorhexidine Gluconate Cloth</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>2% CHG, single application</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Vehicle Cloth</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Excipients on cloth</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Active Chlorhexidine gluconate solution</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Dynahex 2% CHG</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Chlorhexidine gluconate</intervention_name>
    <description>2% CHG solution on cloth</description>
    <arm_group_label>Chlorhexidine Gluconate Cloth</arm_group_label>
    <other_name>CHG</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>DynaHex-2</intervention_name>
    <description>2% CHG solution</description>
    <arm_group_label>Active Chlorhexidine gluconate solution</arm_group_label>
    <other_name>CHG 2%</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Vehicle</intervention_name>
    <description>Excipients of CHG product only</description>
    <arm_group_label>Vehicle Cloth</arm_group_label>
    <other_name>Control</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Males or Females&#xD;
&#xD;
          -  18 years of age or older&#xD;
&#xD;
          -  Signed informed consent&#xD;
&#xD;
          -  Good Health&#xD;
&#xD;
          -  Six inches of abdomen and groin areas without tattoos, or skin disorders&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Dermatological Conditions&#xD;
&#xD;
          -  Sensitivity to latex&#xD;
&#xD;
          -  Sensitivity to CHG&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>R Olsavcszky, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>S.C. BIO HIGH TECH S.R.L.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Bio High Tech SRL</name>
      <address>
        <city>Bucharest</city>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Romania</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>August 16, 2015</study_first_submitted>
  <study_first_submitted_qc>August 16, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 18, 2015</study_first_posted>
  <results_first_submitted>February 3, 2016</results_first_submitted>
  <results_first_submitted_qc>September 1, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">September 28, 2020</results_first_posted>
  <last_update_submitted>September 1, 2020</last_update_submitted>
  <last_update_submitted_qc>September 1, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Preoperative surgical skin preparation</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chlorhexidine</mesh_term>
    <mesh_term>Chlorhexidine gluconate</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Data to be shared with FDA.</ipd_description>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Upon achieving sufficient microbial growth prior to product application on either the abdomen, groin or both abdomen and groin regions,sites of the participant were then randomized to receive one or two products for evaluation for up to 4 sites. Differences in the number of participants is based on microbial qualification.</recruitment_details>
      <pre_assignment_details>The sites of the participant were tested for microbial activity after product application. In some instances, more than one product could have been applied to a participant but only one product per site (groin and/or abdomen sites). Up to 4 sites could be treated: 1) both groin and abdomen, 2) only the groin or 3) only the abdomen.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>CHG Cloth</title>
          <description>CHG, 3 min application</description>
        </group>
        <group group_id="P2">
          <title>Vehicle</title>
          <description>Vehicle 3 min application</description>
        </group>
        <group group_id="P3">
          <title>Comparator CHG</title>
          <description>CHG comparator application</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Abdomen</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="284"/>
                <participants group_id="P2" count="56"/>
                <participants group_id="P3" count="281"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="284"/>
                <participants group_id="P2" count="56"/>
                <participants group_id="P3" count="281"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Groin</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="290"/>
                <participants group_id="P2" count="56"/>
                <participants group_id="P3" count="294"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="290"/>
                <participants group_id="P2" count="56"/>
                <participants group_id="P3" count="294"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>CHG, Vehicle, Comparator CHG</title>
          <description>Single applications of products. 3 min application for CHG and Vehicle. Comparator CHG applied according to instructions.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="340"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="315"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="38" lower_limit="18" upper_limit="69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="182"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="158"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Romania</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="340"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Responder Rates (%) of Sites Identified for Bacterial Reduction on the Abdomen and Groin</title>
        <description>Log10 reduction in bacteria on the skin evaluated at 10 minutes, 6 hours and 8 hours after treatment. Responder rates (%) are the percentage of sites identified that produced a 2-Log and 3-Log reduction from baseline for abdomen and groin sites respectively.</description>
        <time_frame>10 minutes, 6 hours, 8 hours</time_frame>
        <population>Number of participants involved in the analyses.</population>
        <group_list>
          <group group_id="O1">
            <title>CHG 3 Min Abdomen</title>
            <description>single application on abdomen</description>
          </group>
          <group group_id="O2">
            <title>CHG 3 Min Groin</title>
            <description>single application on groin</description>
          </group>
          <group group_id="O3">
            <title>Vehicle Abdomen</title>
            <description>single application on abdomen</description>
          </group>
          <group group_id="O4">
            <title>Vehicle Groin</title>
            <description>single application on groin</description>
          </group>
          <group group_id="O5">
            <title>Comparator CHG Abdomen</title>
            <description>single application on abdomen</description>
          </group>
          <group group_id="O6">
            <title>Comparator CHG Groin</title>
            <description>single application on groin</description>
          </group>
        </group_list>
        <measure>
          <title>Responder Rates (%) of Sites Identified for Bacterial Reduction on the Abdomen and Groin</title>
          <description>Log10 reduction in bacteria on the skin evaluated at 10 minutes, 6 hours and 8 hours after treatment. Responder rates (%) are the percentage of sites identified that produced a 2-Log and 3-Log reduction from baseline for abdomen and groin sites respectively.</description>
          <population>Number of participants involved in the analyses.</population>
          <units>Percent of sites</units>
          <param>Number</param>
          <units_analyzed>Sites</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="284"/>
                <count group_id="O2" value="290"/>
                <count group_id="O3" value="56"/>
                <count group_id="O4" value="56"/>
                <count group_id="O5" value="281"/>
                <count group_id="O6" value="294"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Sites</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="307"/>
                <count group_id="O2" value="291"/>
                <count group_id="O3" value="59"/>
                <count group_id="O4" value="55"/>
                <count group_id="O5" value="314"/>
                <count group_id="O6" value="294"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>10 min</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="78"/>
                    <measurement group_id="O2" value="84"/>
                    <measurement group_id="O3" value="54"/>
                    <measurement group_id="O4" value="56"/>
                    <measurement group_id="O5" value="72"/>
                    <measurement group_id="O6" value="73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100"/>
                    <measurement group_id="O2" value="100"/>
                    <measurement group_id="O3" value="96"/>
                    <measurement group_id="O4" value="100"/>
                    <measurement group_id="O5" value="99"/>
                    <measurement group_id="O6" value="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>8 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="99"/>
                    <measurement group_id="O2" value="100"/>
                    <measurement group_id="O3" value="96"/>
                    <measurement group_id="O4" value="100"/>
                    <measurement group_id="O5" value="98"/>
                    <measurement group_id="O6" value="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>CHG Cloth Abdomen</title>
          <description>CHG, 3 min application to abdomen</description>
        </group>
        <group group_id="E2">
          <title>Vehicle Abdomen</title>
          <description>Vehicle 3 min application to abdomen</description>
        </group>
        <group group_id="E3">
          <title>Comparator CHG Abdomen</title>
          <description>CHG comparator applied to abdomen</description>
        </group>
        <group group_id="E4">
          <title>CHG Cloth Groin</title>
          <description>CHG, 3 min application to groin</description>
        </group>
        <group group_id="E5">
          <title>Vehicle Groin</title>
          <description>Vehicle 3 min application to groin</description>
        </group>
        <group group_id="E6">
          <title>Comparator CHG Groin</title>
          <description>CHG comparator applied to groin</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="284"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="281"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="290"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="294"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="284"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="281"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="290"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="294"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>Confidential information based on contract.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Olsavszky</name_or_title>
      <organization>Evic Romania</organization>
      <phone>40 21 335 70 90</phone>
      <email>research@evic.ro</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

